Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002435354 | SCV002752723 | pathogenic | Hereditary cancer-predisposing syndrome | 2022-03-29 | criteria provided, single submitter | clinical testing | The c.285_300del16 pathogenic mutation, located in coding exon 2 of the MSH2 gene, results from a deletion of 16 nucleotides at nucleotide positions 285 to 300, causing a translational frameshift with a predicted alternate stop codon (p.R96Kfs*73). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |